Topical oxygen therapy billing FAQ: E0446, A4575, and 99199
reimbursement
Common billing and coverage questions on topical oxygen for diabetic foot ulcers — codes, frequency, documentation, and what triggers a denial.
Topical oxygen has its own coding quirks. These are the questions revenue cycle and clinicians keep asking under LCD DL33797.
What codes bill for topical oxygen therapy?
E0446 covers the topical oxygen delivery system and A4575 covers the disposable supply. Physician services fold into 99199 with no separate payment. All three fall under DME jurisdiction.
When does a diabetic foot ulcer qualify?
The wound must show less than 50% area reduction after four weeks of optimized standard care. The patient needs diabetes with HbA1c under 12%, adequate perfusion at the foot, and no osteomyelitis, gangrene, active infection, same-limb DVT, or malignancy.
What documentation triggers denials?
Missing baseline measurements, no dated HbA1c, absent perfusion assessment, or an incomplete four-week standard-care trial. The chart has to show each LCD criterion explicitly. See how WISER pre-checks claims against LCD language.
Can I bill topical oxygen with a skin substitute in the same episode?
Generally no — payers view them as overlapping advanced therapies. Sequence carefully and document the clinical rationale for switching. Related: skin substitutes after the 2026 CMS rule.
How often can the supply (A4575) be billed?
Billing frequency follows the DME MAC's utilization guidelines for the specific device. Chart each application and outcome so utilization matches the treatment plan.
What if the wound isn't healing after topical oxygen starts?
Reassess at defined intervals. Continued coverage depends on documented progress. The healing dashboard tracks trajectory so you know when to escalate or stop.
Start your free trial at WoundScribe AI.